09 May, EOD - Indian

SENSEX 79454.47 (-1.10)

Nifty 50 24008 (-1.10)

Nifty Bank 53595.25 (-1.42)

Nifty IT 35880.1 (-0.34)

Nifty Midcap 100 53223.35 (-0.01)

Nifty Next 50 62527 (-0.37)

Nifty Pharma 21071.75 (-0.21)

Nifty Smallcap 100 16085.65 (-0.61)

09 May, EOD - Global

NIKKEI 225 37503.33 (1.56)

HANG SENG 22867.74 (0.40)

S&P 5696 (-0.01)

LOGIN HERE

companylogoModi Naturals Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 519003 | NSE Symbol : | ISIN : INE537F01012 | Industry : Solvent Extraction |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
24-Feb-2025 24-Feb-2025 Change in Other Executives Appointment of Company Secretary and Compliance Officer
22-Jan-2025 28-Jan-2025 Quarterly Results Modi Naturals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 inter alia to consider and approve the Unaudited Financial Results (standalone and consolidated) of the Company for the quarter ended on 31st December 2024 Outcome of Board Meeting held on today i.e. 28th January, 2025 (As Per Bse Announcement Dated on 28.01.2025)
18-Oct-2024 25-Oct-2024 Quarterly Results Modi Naturals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve unaudited financial results. Unaudited Financial Result for the quarter ended 30th September, 2024. (As Per BSE Announcement dated on 25.10.2024)
06-Sep-2024 06-Sep-2024 AGM Outcome of Board Meeting - Regulation 30 of SEBI (LODR) Regulations, 2015
24-Jul-2024 30-Jul-2024 Quarterly Results Modi Naturals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2024 inter alia to consider and approve the Unaudited Financial Results (standalone and consolidated) of the Company for the quarter ended on 30th June 2024. Outcoem of Board Meeting held on 30th July 2024 (As Per BSE Announcement Dated on: 30/07/2024)
23-May-2024 30-May-2024 Accounts Modi Naturals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the Audited Financial Results (standalone and consolidated) of the Company for the quarter and year ended on 31st March 2024. Audited Financial Results (standalone & consolidated) for the quarter and year ended March 31 2024 Outcome of Board Meeting held on 30th May, 2024 Audited Financial Results (standalone & consolidated) for the FY ended March 31, 2024 along with auditor reports thereon (As Per BSE Announcement Dated on 30.05.2024)
08-Feb-2024 14-Feb-2024 Quarterly Results Modi Naturals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Unaudited Financial Results (standalone and consolidated) of the Company for the quarter ended on 31st December 2023. Outcome of Board Meeting held on 14th February, 2024 Financial results (standalone & consolidated) for quarter ended 31st December 2023 (As Per BSE Announcement Dated on 14/02/2024)
17-Nov-2023 17-Nov-2023 Conversion Allotment of 230900 equity shares to Promoter and Promoter Group upon conversion of warrants
23-Oct-2023 30-Oct-2023 Quarterly Results Modi Naturals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2023 inter alia to consider and approve the Unaudited Financial Results (standalone and consolidated) of the Company for the quarter ended on 30th September 2023. The Board of Directors of the Company at its meeting held today i.e. 30.10.2023 has, inter alia, considered and approved the allotment of 2,07,537 equity shares to Promoter/ Promoter group upon conversion of warrants. Outcome of Board Meeting held on 30th October 2023 Financial Results (standalone and consolidated) for quarter ended 30th September 2023 (As per BSE Announcement Dated on 30/10/2023)
20-Oct-2023 20-Oct-2023 Change in Auditors The Board of Directors of the Company at its meeting held today i.e. 20.10.2023 has considered and approved the following: 1. Allotment of 211563 equity shares to Promoter & Promoter Group upon conversion of warrants; 2. Re-appointment of Internal auditors for FY 2023-24
05-Sep-2023 05-Sep-2023 AGM Intimation of appointment of Statutory Auditor and reappointment of Cost Auditor
05-Aug-2023 11-Aug-2023 Quarterly Results Modi Naturals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Unaudited Financial Results (standalone and consolidated) of the Company for the quarter ended on 30th June 2023. Outcome of Board Meeting held on 11th August, 2023 (As Per BSE Announcement dated on 11.08.2023)
23-May-2023 30-May-2023 Quarterly Results Modi Naturals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve the Audited Financial Results (standalone and consolidated) of the Company for the quarter and year ended on 31st March 2023. Outcome of Board Meeting held on 30th May, 2023 Audited Financial Results for the Quarter and Year ended on 31st March 2023 Intimation of reappointment of Secretarial Auditors of the Company for FY 2022-23 (As Per BSE Announcement dated on 30.05.2023)
06-Feb-2023 14-Feb-2023 Quarterly Results Modi Naturals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the Unaudited Financial Results (standalone and consolidated) of the Company for the 3rd Quarter and nine months ended on 31st December 2022. Outcome of the Board Meeting held on 14th February 2023 and submission of Unaudited Financial Results (standalone and consolidated) for quarter and nine months ended December 31, 2022 (As Per BSE Announcement Dated on 14.02.2023)
04-Nov-2022 14-Nov-2022 Quarterly Results Modi Naturals Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve the Unaudited Financial Results (standalone and consolidated) of the Company for the quarter ended September 30 2022. Unaudited Financial Results (Standalone & Consolidated ) for the quarter and half year ended September 30, 2022, along with limited review report from the statutory auditors of the company thereon. (As Per BSE Announcement Dated on 14.11.2022)
1 2 

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +